Molecular Systems Biology-An Open access

Molecular Systems Biology


About Molecular Systems Biology

As systems biology requires the integration and co-ordination of many data sets,Molecular Systems Biology makes all content freely available to all researchers worldwide, ensuring maximum dissemination of content through the nature.com platform. Content is published online on a weekly basis to provide timely communication to the community and keep publication times to a minimum.

Benefits of publishing in Molecular Systems Biology

  • Fast submission and review process
  • Research reaches the community in a timely manner
  • Guaranteed quality - peer review managed by top editors
  • All content is free to all - worldwide
  • Sophisticated online presentation - innovative formats, interactive figures
  • Synopses - letting authors to further explain their research
  • Submissions can be made in SBML (Systems Biology Mark-up Language) - allowing you to integrate your research with databases and other resources easily
  • High readership visibility - nature.com hosting makes sure papers are noticed. Exceptional papers are press released

Creative Commons Licence

Molecular Systems Biology articles are published either under a Creative Commons Attribution 3.0 Unported Licence, Creative Commons Attribution-Noncommercial-Share Alike 3.0 licence or a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 licence, at the free choice of the authors.
Under the Creative Commons Attribution 3.0 Unported Licence (CC BY), users are free to share (copy, distribute and transmit) and to adapt (edit, rewrite or remix) the contribution including for commercial purposes, but with formal attribution. Users must attribute the contribution in the manner specified by the author or licensor (but not in any way that suggests that they or their use of the contribution is endorsed by the author or licensor). 

The use of the CC-BY licence is mandatory for open access publication by recipients of funding from Research Councils UK (RCUK) and the Wellcome Trust after April 2013.
EMBO encourages use of the CC-BY licence. The CC-BY licence facilitates the sharing of scientific information, while mandating citation of the source. This is particularly important for academic re-use of the data, such as for systematic literature analysis.
Under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License, users are free to share (copy, distribute and transmit) and to adapt (edit, rewrite or remix) the contribution under the following conditions (see full legal code at http://creativecommons.org/licenses/by-nc-sa/3.0/):
  • Attribution. Users must attribute the contribution in the manner specified by the author or licensor (but not in any way that suggests that they or their use of the contribution is endorsed by the author or licensor).
  • NonCommercial. Users may not use this work for commercial purposes.
  • Share Alike. If users alter, transform, or build upon this work, they may distribute the resulting work only under the same or similar licence to this one.
Under the Creative Commons Attribution-NonCommercial-No Derivative Works 3.0 Unported License, users are free to share (copy, distribute and transmit) the contribution under the following conditions (see full legal code athttp://creativecommons.org/licenses/by-nc-nd/3.0/):
  • Attribution. Users must attribute the contribution in the manner specified by the author or licensor (but not in any way that suggests that they or their use of the contribution is endorsed by the author or licensor).
  • NonCommercial. Users may not use this contribution for commercial purposes.
  • No derivative works. Users may not alter, transform, or build upon this work.
None of these Creative Commons Licence impairs or restricts the author’s moral rights. Additionally, the following terms hold:
  • For any reuse or distribution, users must make clear to others the license terms of this work, preferably using a link to the Creative commons webpage
  • Any of the above conditions can be waived if users get permission from the copyright holder.
Please note that any file labeled “Source Data”, “Dataset” or “Resource” is released under a Creative Commons CC0 1.0 Universal Licence (legal code athttp://creativecommons.org/publicdomain/zero/1.0). This allows unrestricted re-use without the explicit requirement of attribution. We encourage attribution where this is warranted by good scholarly practice.

Open Access and Charges

Molecular Systems Biology levies an article-processing charge of $3,900 per article accepted for publication (Research Articles and Reports). Correspondences evaluated by reviewers are subject to a publication fee of $900. Correspondences that are not peer reviewed are subject to a reduced processing fee of $500.
Upon acceptance of their manuscript authors of articles and reports should complete the charge payment form and licence to publish form and return to NPG's production department (fax number included on form). We can waive charges for authors that can justify their claim that they are unable to bear the costs of publication or those from low-income countries. Queries about the modalities of payment of the article-processing charges should imperatively be addressed to the editorial office within 14 days upon receipt of the final decision letter.
Processing of an accepted manuscript can only proceed once the charge payment form and licence to publish have been returned to Nature Publishing Group.